G1 expression and multistage dynamics of cyclin A in human osteosarcoma cells.
Cyclin A was initially characterized as a 'mitotic cyclin', believed to function exclusively at the G2-to-M phase transition; however, recent studies have provided compelling evidence that cyclin A additionally functions earlier in the mammalian somatic cell cycle as a putative 'S-phase-promoting factor'. Moreover, numerous inconsistencies have arisen concerning the temporal induction, subcellular localization, subunit configuration, covalent modification and proteolytic destruction of cyclin A, as well as the physiological function of the cyclin A-associated protein kinase complexes. Utilizing precisely synchronized human MG-63 osteosarcoma cells, the present study demonstrates that cyclin A mRNA and protein are clearly expressed in late G1 prior to S-phase entry, as is cyclin A-associated kinase activity and concomitant phosphorylation of the Rb protein. A series of monospecific cyclin A antibodies were generated and utilized to confirm that multiple covalent modifications of cyclin A occur during the course of the cell cycle, and to characterize the subcellular dynamics in additional detail. Pharmacological blockade with mimosine was utilized to further delineate cyclin A expression and to distinguish the temporal induction from the mechanisms of enzyme activation. Subcellular fractionation and immunocytochemical staining localized nascent cyclin A to the cytoplasm, and revealed a distinct translocation to the nucleus during the G1-to-S phase transition. The results of these studies support a multistage model of cyclin A metabolism and enzyme activation.
Carbonaro-Hall
D
D
Division of Orthopaedic Surgery, Children's Hospital of Los Angeles, CA 90054-0700.
Williams
R
R
Wu
L
L
Warburton
D
D
Zeichner-David
M
M
MacDougall
M
M
Tolo
V
V
Hall
F
F
D000595:Amino Acid Sequence; D000911:Antibodies, Monoclonal; D015152:Blotting, Northern; D016203:CDC2 Protein Kinase / Q000032:analysis; D002453:Cell Cycle / Q000502:physiology*; D002455:Cell Division / Q000187:drug effects; D002467:Cell Nucleus / Q000378:metabolism; D016213:Cyclins / Q000032:analysis / Q000096:biosynthesis* / Q000235:genetics; D005434:Flow Cytometry; D016193:G1 Phase; D006801:Humans; D007150:Immunohistochemistry; D007700:Kinetics; D008898:Mimosine / Q000494:pharmacology; D008969:Molecular Sequence Data; D008970:Molecular Weight; D012516:Osteosarcoma; D012334:RNA, Neoplasm / Q000235:genetics / Q000302:isolation & purification; D016196:S Phase; D013936:Thymidine / Q000378:metabolism; D014407:Tumor Cells, Cultured
D000911:Antibodies, Monoclonal; D016213:Cyclins; D012334:RNA, Neoplasm; D008898:Mimosine; D016203:CDC2 Protein Kinase; D013936:Thymidine